- Home
- ABTC vs GLSI Comparison
ABTC vs GLSI Comparison
Compare ABTC & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTC
- GLSI
- Stock Information
- Founded
- ABTC 2024
- GLSI 2006
- Country
- ABTC United States
- GLSI United States
- Employees
- ABTC N/A
- GLSI N/A
- Industry
- ABTC EDP Services
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- ABTC Technology
- GLSI Health Care
- Exchange
- ABTC Nasdaq
- GLSI Nasdaq
- Market Cap
- ABTC 122.5M
- GLSI 145.2M
- IPO Year
- ABTC N/A
- GLSI 2020
- Fundamental
- Price
- ABTC $5.09
- GLSI $9.21
- Analyst Decision
- ABTC
- GLSI Strong Buy
- Analyst Count
- ABTC 0
- GLSI 1
- Target Price
- ABTC N/A
- GLSI $39.00
- AVG Volume (30 Days)
- ABTC 2.7M
- GLSI 67.0K
- Earning Date
- ABTC 11-14-2025
- GLSI 11-14-2025
- Dividend Yield
- ABTC N/A
- GLSI N/A
- EPS Growth
- ABTC N/A
- GLSI N/A
- EPS
- ABTC 2.64
- GLSI N/A
- Revenue
- ABTC $69,890,000.00
- GLSI N/A
- Revenue This Year
- ABTC N/A
- GLSI N/A
- Revenue Next Year
- ABTC N/A
- GLSI N/A
- P/E Ratio
- ABTC $1.93
- GLSI N/A
- Revenue Growth
- ABTC 6.38
- GLSI N/A
- 52 Week Low
- ABTC $4.31
- GLSI $8.06
- 52 Week High
- ABTC $14.52
- GLSI $15.47
- Technical
- Relative Strength Index (RSI)
- ABTC N/A
- GLSI 37.30
- Support Level
- ABTC N/A
- GLSI $9.11
- Resistance Level
- ABTC N/A
- GLSI $10.22
- Average True Range (ATR)
- ABTC 0.00
- GLSI 0.54
- MACD
- ABTC 0.00
- GLSI -0.03
- Stochastic Oscillator
- ABTC 0.00
- GLSI 15.99
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.